Oxford University Press, The Journal of Clinical Endocrinology & Metabolism, 4(95), p. 1626-1633, 2010
DOI: 10.1210/jc.2009-1743
Full text: Download
Context: From preliminary observations, GH-IGF-I seems to be compromised in men with aromatase deficiency. The GH deficiency (GHD) coexists paradoxically with tall stature, raising the question whether or not a true GHD is part of this rare syndrome. Objective: To evaluate the GH secretion in aromatase-deficient men, their GH response to the GHRH plus arginine (GHRH-ARG) test was compared with that of normal subjects. The effect of estrogen replacement treatment on the GH-IGF-I axis in aromatase-deficient men was evaluated before and during therapy. Design and Setting: A case-control study was conducted. Patients: Four adult men with aromatase deficiency were compared with 12 normal subjects. Main Outcome Measures: We measured the GH response to GHRH-ARG in aromatase-deficient men (at baseline and during estrogen treatment) and in normal subjects. Basal serum IGF-I was measured in both patients and controls. Results: The response of GH to GHRH-ARG was severely impaired in men with aromatase deficiency and resulted in significantly lower (P